CAT# | CP16706 |
CAS | 205526-27-8 |
Synonyms/Alias | 205526-27-8;Fmoc-L-3-Trifluoromethylphenylalanine;Fmoc-Phe(3-CF3)-OH;FMOC-L-3-Trifluoromethylphe;Fmoc-3-Trifluoromethyl-L-Phenylalanine;Fmoc-3-(trifluoromethyl)-L-phenylalanine;Fmoc-D-3-Trifluoromethylphenylalanine;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[3-(trifluoromethyl)phenyl]propanoicacid;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-[3-(trifluoromethyl)phenyl]propanoicacid;(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-(trifluoromethyl)phenyl)propanoicacid;(2S)-2-([(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO)-3-[3-(TRIFLUOROMETHYL)PHENYL]PROPANOICACID;3-(Trifluoromethyl)-L-phenylalanine,N-FMOCprotected;AC1ODU24;47833_ALDRICH;SCHEMBL120604;Jsp004214;47833_FLUKA;CTK8C5623;MolPort-001-778-397;ZINC2567691;CF-648;AKOS015837241;AKOS015912192;AB06828;AM83494 |
M.F/Formula | C25H20F3NO4 |
M.W/Mr. | 455.43 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
KAI-1455, a ε-protein kinase C activator in Phase I testing for the treatment of ischemia-induced reperfusion i ...
NoxA1ds is derived from a peptide whose structure is based on a short sequence of an essential Nox subunit. It b ...
Studies on the binding affinities of darifenacin hydrobromide and human muscarinic receptor subtypes show strong ...
Timonacic's chemical name, L-Syrosin-4, is a new anti-tumor drug that converts cancer cells into normal cells. E ...
Histrelin acetate, sold under many brand name like Vantas, Supprelin LA and others, is a nonapeptide analog of g ...